Dr. Siegel on Study of Induction Chemotherapy and Transoral Surgery in Oropharyngeal Cancer

Robert Siegel, MD
Published: Tuesday, Aug 22, 2017



Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses a study of induction chemotherapy and transoral surgery in patients with oropharyngeal cancer.

In a phase II study, the efficacy of induction chemotherapy and transoral surgery was studied as a definitive treatment for oropharyngeal squamous cell carcinoma.

Through this regimen, Siegel hopes to eliminate the morbidly of radiation therapy, which is the current standard of care for these patients.
 


Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses a study of induction chemotherapy and transoral surgery in patients with oropharyngeal cancer.

In a phase II study, the efficacy of induction chemotherapy and transoral surgery was studied as a definitive treatment for oropharyngeal squamous cell carcinoma.

Through this regimen, Siegel hopes to eliminate the morbidly of radiation therapy, which is the current standard of care for these patients.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations Across Lung, Head and Neck, and Bladder CancersApr 28, 20182.0
Publication Bottom Border
Border Publication
x